SecBot SecBot
SC 13G ·Filed Nov 12, 2026

MDXG

MIMEDX GROUP, INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed4d 11h ago SEC0001104659-26-126232
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any amendment to SC 13D if Trigran's intent shifts from passive to active, particularly given the company's recent revenue decline. The 5.1% stake is just above the 5% threshold, indicating a modest position rather than a strong conviction bet.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1
Entry
$3.21
T+0 close · Nov 12, 2026 · via day close
Latest settled
−0.93%
T+1 · $3.18
Vs SPY
+0.98%
α at T+1
Next horizon
T+5
in 3d
  1. T+0 · Nov 13 $3.21entry
  2. T+1 · 20h ago −0.93%α +0.98% · $3.18
  3. T+5 · in 3d Pending
  4. T+20 · in 27d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Trigran Investments, Inc. and its controlling shareholders disclosed a 5.1% passive stake in MiMedx Group via a Schedule 13G filed on November 12, 2026, with beneficial ownership of 7,391,329 shares as of September 30, 2026. The filing certifies passive intent and comes 15 days after MiMedx reported a 45% YoY revenue decline in Q3 2026, suggesting the stake was accumulated during or after the earnings sell-off.

Key Financial Metrics

Stake
5.1%
Investor
Trigran Investments, Inc.

Key Facts

  • Trigran Investments, Inc. and five individuals (Douglas T. Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, Steven R. Monieson) filed a joint Schedule 13G on November 12, 2026.
  • Beneficial ownership: 7,391,329 shares of common stock, representing 5.1% of shares outstanding as of September 30, 2026.
  • The filing certifies passive intent under Rule 13d-1(b), stating shares were acquired and are held in the ordinary course of business, not to change or influence control.
  • The stake was accumulated by September 30, 2026, predating MiMedx's Q3 2026 earnings report (filed October 28, 2026) which showed net sales of $62M, down 45% YoY.
  • Each reporting person disclaims beneficial ownership except to the extent of pecuniary interest.

Financial Impact

5.1% passive stake in MiMedx Group; no transaction value disclosed in the filing.

ownership concentration

Risk Factors

  • Passive certification could be challenged if Trigran engages with management or seeks board representation, potentially requiring conversion to SC 13D.
  • The stake was accumulated before the Q3 earnings miss, raising questions about the investment thesis post-revenue decline.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001104659-26-126232
Document: 0001104659-26-126232-index-headers.html0001104659-26-126232
Document: 0001104659-26-126232-index.html0001104659-26-126232
Document: 0001104659-26-126232.txt0001104659-26-126232

Track record

10 reports on MDXG

Performance horizon

4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +26.86% at T+20 after the Oct 16, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 12, 20264d ago SC 13G Neutral 4/10 Viewing Entry $3.21 Now $3.18 −0.93% settles Nov 20
  2. Oct 28, 202619d ago 8-K Bearish 6/10 No price data
  3. Oct 28, 202619d ago Press Release Bearish 6/10 Entry $3.97 to $3.28 Now $3.18 +19.90% ▲ +17.38% +12.65% vs SPY
  4. Oct 28, 202619d ago Press Release Bullish 5/10 Entry $3.97 to $3.28 Now $3.18 −19.90% ▼ −17.38% −12.65% vs SPY
  5. Oct 16, 20264w ago 425 Mixed 5/10 Entry $4.43 to $3.91 Now $3.18 −28.22% ▼ −11.74% −11.83% vs SPY
  6. Oct 16, 20264w ago 8-K Bearish 6/10 Entry $4.43 to $3.91 Now $3.18 +28.22% ▲ +11.74% +11.83% vs SPY
  7. Jun 2, 202624w ago Court Ruling Bullish 5/10 Entry $3.57 to $3.71 Now $3.18 −10.92% ▲ +3.92% +6.89% vs SPY
  8. Apr 29, 202628w ago DEFA14A Neutral 3/10 Entry $3.36 to $3.66 Now $3.18 −5.36% ▲ +8.93% +7.20% vs SPY
  9. Apr 22, 202629w ago Press Release Neutral 1/10 Entry $3.31 to $3.27 Now $3.18 −3.93% ▼ −1.36% −1.41% vs SPY
  10. Apr 16, 202630w ago 8-K Bearish 7/10 Entry $3.43 to $3.35 Now $3.18 +7.29% ▲ +2.33% +3.32% vs SPY
Showing 10 of 10

US Market Status

Market Closed · Opens in 6h 13m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 12, 2026